The Exciting Opportunities That Radiopharmaceuticals Have to Offer: Nuclear Medicine Imaging, Therapy and Drug Delivery Systems
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: 30 November 2025 | Viewed by 19
Special Issue Editors
Interests: PET imaging; radiochemistry; molecular imaging probes; neuroimaging; radiopharmaceutical development
2. Laboratory of Nanoradiopharmacy, Rio de Janeiro State University, Rio de Janeiro 23070-200, Brazil
Interests: radiopharmacy; radiopharmaceuticals; nano-radiopharmaceuticals; nanotechnology; nanoparticles and theranostics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Radiopharmaceuticals play a transformative role in nuclear medicine by enabling both precise imaging and targeted treatment at the molecular level. With the growing need for non-invasive diagnostic tools and effective site-specific therapies, this field offers unprecedented opportunities across oncology, neurology, cardiology, and more. Recent innovations in radiochemistry, molecular probe design, and drug delivery platforms have significantly enhanced the specificity, bioavailability, and therapeutic index of these agents. Advances in targeted radionuclide therapy (TRT), including alpha- and beta-emitting isotopes, have opened up new therapeutic pathways for combatting cancer and inflammatory diseases. At the same time, engineering drug delivery systems—such as nanocarriers and ligand-conjugated scaffolds—has improved the in vivo stability, biodistribution, and cell/tissue penetration of radiopharmaceuticals.
This Special Issue aims to gather original research and reviews on cutting-edge developments in the design, synthesis, and application of radiopharmaceuticals for both diagnostic and therapeutic purposes. Topics of interest include novel imaging probes, PET/SPECT tracers, theranostic agents, and innovative drug delivery approaches for crossing biological barriers. Contributions highlighting the translational and clinical potential of radiopharmaceuticals are particularly welcome. We hope this collection will provide new insights into how radiopharmaceuticals are reshaping modern medicine.
Dr. Yanli Wang
Dr. Ralph Santos-Oliveira
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- PET imaging
- theranostics
- molecular imaging probes
- radionuclide therapy
- neuroimaging
- radiochemistry
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
